|Day Low/High||0.04 / 0.04|
|52 Wk Low/High||0.01 / 0.08|
GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.
A Landmark Moment as Online Store is Open for Business Now
Visit Andrew Pitsicalis, CEO of Purple Haze Properties, Today in Chicago, Representing Individual & Joint Medicinal Products Created with CBIS for 'Jimi's Cannabis Collection' Including Genetic Strains & Products
DR. ALLEN HERMAN, WORLD-RENOWNED EPIDEMIOLOGIST & SOUTH AFRICAN NATIONAL SCHOOL OF PUBLIC HEALTH DEAN & FOUNDER JOINS CBIS SAB
THE REPORT BOASTS STRONG SCIENTIFIC MANAGEMENT AND PARTNERS IN A MEDICAL CANNABINOID INDUSTRY ESTIMATED AT $2.7 BILLION AND RISING YEARLY
The Bi-Partisan Bill was Introduced at a Press Conference by Senators Rand Paul (R-Ky.), Cory Booker (D-N.J.), and Kirsten Gillibrand (D-N.Y.), Would End the Federal Prohibition
The Release of the European Product Line will Feature Cannabis Science Proprietary Formulations Developed in Spain and the Netherlands
Openfolio surveyed the portfolios of its pool of over 20,000 investors to see the effect penny stocks have on overall performance.
Cannabis Science and Raymond C. Dabney Joins the Fight for a Better African Healthcare Infrastructure
Raymond C. Dabney Joins the Fight for a Better African Healthcare Infrastructure